General Information of DTT (ID: TTEAD9J)

DTT Name Proteasome beta-8 (PS beta-8) DTT Info
Gene Name PSMB8

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Investigative Drug(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
M3258 DM6PI5B Multiple myeloma 2A83 Phase 1 [1]
------------------------------------------------------------------------------------
30 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dipeptide analog 1 DM2OTJS N. A. N. A. Patented [2]
Peptide analog 11 DML9C64 N. A. N. A. Patented [2]
Peptide analog 13 DMWI6V3 N. A. N. A. Patented [2]
Peptide analog 17 DMJ91EM N. A. N. A. Patented [2]
Peptide analog 19 DMLIVT6 N. A. N. A. Patented [2]
Peptide analog 21 DMJDFS1 N. A. N. A. Patented [2]
Peptide analog 23 DMDU21R N. A. N. A. Patented [2]
Peptide analog 25 DMFBQHZ N. A. N. A. Patented [2]
Peptide analog 27 DML4XJ2 N. A. N. A. Patented [2]
Peptide analog 28 DMHT4PF N. A. N. A. Patented [2]
Peptide analog 31 DMS9O6I N. A. N. A. Patented [2]
Peptide analog 33 DML5P6O N. A. N. A. Patented [2]
Peptide analog 34 DMG4EOP N. A. N. A. Patented [2]
Peptide analog 41 DM96KXE N. A. N. A. Patented [2]
PMID29865878-Compound-43 DMQUE6D N. A. N. A. Patented [2]
PMID29865878-Compound-44 DMRTQ4I N. A. N. A. Patented [2]
PMID29865878-Compound-46 DMP3MXK N. A. N. A. Patented [2]
PMID29865878-Compound-48 DMVQTR2 N. A. N. A. Patented [2]
PMID29865878-Compound-49 DMK0GTV N. A. N. A. Patented [2]
PMID29865878-Compound-51 DM0LXT2 N. A. N. A. Patented [2]
PMID29865878-Compound-53 DM6JV1W N. A. N. A. Patented [2]
PMID29865878-Compound-55 DMY52ZB N. A. N. A. Patented [2]
PMID29865878-Compound-57 DM3VQ1Y N. A. N. A. Patented [2]
PMID29865878-Compound-58 DMO108N N. A. N. A. Patented [2]
PMID29865878-Compound-59 DMM73VG N. A. N. A. Patented [2]
PMID29865878-Compound-61 DMG7VF1 N. A. N. A. Patented [2]
PMID29865878-Compound-62 DML47KS N. A. N. A. Patented [2]
PMID29865878-Compound-63 DMEM2I8 N. A. N. A. Patented [2]
PMID29865878-Compound-64 DM1U6H2 N. A. N. A. Patented [2]
PMID29865878-Compound-8 DMX1E6O N. A. N. A. Patented [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 30 Patented Agent(s)
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
HT1042 DMZRPM5 Discovery agent N.A. Investigative [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of EMD Serono.
2 A patent review of immunoproteasome inhibitors.Expert Opin Ther Pat. 2018 Jul;28(7):517-540.
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2408).